90.9 WBUR - Boston's NPR news station
Top Stories:
PLEDGE NOW
Here and Now with Robin Young
Public radio's live
midday news program
With sponsorship from
Mathworks - Accelerating the pace of engineering and science
Accelerating the pace
of engineering and science
Thursday, January 10, 2013

Cancer-Screening Power of Pap Test Is Expanding

Bradley M. Linzie, MD, FCAP, explains to Precious Marshall of Minneapolis, Minn., her Pap test slide at NorthPoint Health & Wellness Clinic in Minneapolis, Minn. in October. (College of American Pathologists/PRNewsfoto)

Bradley M. Linzie, MD, FCAP, explains to Precious Marshall of Minneapolis, Minn., her Pap test slide at NorthPoint Health & Wellness Clinic in Minneapolis, Minn. in October. (College of American Pathologists/PRNewsfoto)

Researchers at Johns Hopkins University been able to use samples collected from a Pap smear to indicate the presence of endometrial and ovarian cancers.

A pap test is a routine gynecological test used to screen for cervical cancer. Using a brush, cells are scraped from the cervix and examined for signs of mutation which would indicate cancer.

Dr. Luis Diaz and his research team have used genetic testing on samples collected in the same way to test for ovarian cancer and endometrial cancer, a cancer of the uterus.

A research paper published in the journal Science Translational Medicine showed that preliminary tests on 46 women were able to detect all 24 cases of endometrial cancer and nine of the 22 cases of ovarian cancer.

The difference in result seems to be proximity of the effected organs to the cervix. The test looks at cells shed by tumors; the closer the tumor is to the cervix the more cells there are to test.

Scientists will explore getting cells from further inside the cervix and and different points during the menstrual cycle to improve the tests.

While the research is in it’s preliminary stages and tests will not be used on patient samples for a while, the pap test will not change at all for patients.

Up until this point, there were no screening tests for ovarian or endometiral cancer.

More than 22,000 U.S. women are diagnosed with ovarian cancer each year, and more than 15,000 die. Endometrial cancer affects about 47,000 women a year, and kills about 8,000.

Guest:


Please follow our community rules when engaging in comment discussion on this site.
  • http://www.facebook.com/profile.php?id=100003000884786 Navin R Johnson

    “Up until this point, there were no screening tests for ovarian or endometrial cancer.”

    Alas, there still is no screening test for ovarian or endometrial cancer.  This is a very preliminary study, and the result for ovarian screening is not promising.  I question the widespread dissemination of this story in the media when the results are essentially meaningless at this time.

    • fashionplate

      Yuxuan Wang while on “Here & Now” acknowledged that it will take approximately 10 years before the test is available to the general public.

  • Sadfsf
Robin and Jeremy

Robin Young and Jeremy Hobson host Here & Now, a live two-hour production of NPR and WBUR Boston.

April 22 Comment

What Do We Have To Teach Plato?

Philosopher Rebecca Newberger Goldstein discusses her new book "Plato at the Googleplex: Why Philosophy Won't Go Away."

April 22 18 Comments

Children’s Literature: Apartheid Or Just A General Lack of Color?

African-American children's book authors Walter Dean Myers and his son Christopher Myers weigh in.

April 21 Comment

Remembering Rubin ‘Hurricane’ Carter

We remember the boxing champion, who was twice wrongly convicted of murder, with his longtime friend and defender.

April 21 2 Comments

‘Wait Wait’ Host Peter Sagal Runs Boston Marathon As Guide

For the second year in a row, the host of NPR's "Wait Wait... Don't Tell Me" is running with a legally blind athlete.